Janssen
Janssen
See all stories about Janssen, a pharmaceutical company of Johnson & Johnson
What you need to know about Johnson & Johnson’s 2023 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.
Behind the relentless pursuit of multiple myeloma cures
Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
What you need to know about Johnson & Johnson’s 2023 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
5 things we now know about myasthenia gravis
For National Autoimmune Disease Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.
“My battle with IBD has fueled my passion for helping patients like me”
Sid Jain, a leader on the pharmaceutical R&D data science team at Johnson & Johnson, knows that new and better treatment options change lives. And being a Crohn’s disease patient himself has supercharged his mission to help revolutionize the research process.
What are clinical trials?
Behind every innovative medicine, treatment and therapy is a clinical trial. For Clinical Trials Day, here’s a closer look at how they work.
What you need to know about Johnson & Johnson’s 2023 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Johnson & Johnson named to Fortune‘s 2023 America’s Most Innovative Companies list
The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson’s mission to improve health for people across the globe for over a century.
What is a rare disease?
It’s estimated that over 300 million people around the globe are living with a rare disease. For Rare Disease Day, here’s what to know.
5 things we now know about peripheral artery disease
The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.